iPSC-Alveolar Type II Cells
Discover iPSC-Alveolar Type II Cells, a human iPSC-derived model for alveolar epithelial research.
TAKE THE FIRST STEP
ABOUT US
Predict future safety and efficacy more efficiently
For more than a decade, Ncardia has been pioneering innovations in human induced pluripotent stem cells (iPSC). Our iPSC drug discovery platforms have been successfully leveraged by large biopharmas, up-and-coming drug discovery firms and multinational research consortia to advance therapeutic candidates for cardiovascular, neurological and other disease areas.